Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRI Bio, Inc. stock logo
GRI
GRI Bio
$2.88
+25.8%		$1.73
$1.36
▼
$80.36
$6.30M-1.24508,950 shs7.41 million shs
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
$0.17
+0.9%		$0.33
$0.15
▼
$3.05
$10.87M0.126.01 million shs15.10 million shs
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$0.37
+0.9%		$0.39
$0.24
▼
$2.60
$15.19M3.253.51 million shs141,105 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
$4.32
$1.11
▼
$17.50
$15.17M0.163,006 shsN/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRI Bio, Inc. stock logo
GRI
GRI Bio
+25.76%+50.00%+88.24%+44.00%-92.95%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
+0.88%-33.26%-42.05%-50.86%-91.36%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
+0.87%-5.33%-4.11%+3.61%-61.53%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00%-15.69%-10.00%+18.03%-78.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRI Bio, Inc. stock logo
GRI
GRI Bio
$2.88
+25.8%		$1.73
$1.36
▼
$80.36
$6.30M-1.24508,950 shs7.41 million shs
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
$0.17
+0.9%		$0.33
$0.15
▼
$3.05
$10.87M0.126.01 million shs15.10 million shs
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$0.37
+0.9%		$0.39
$0.24
▼
$2.60
$15.19M3.253.51 million shs141,105 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$3.60
$4.32
$1.11
▼
$17.50
$15.17M0.163,006 shsN/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRI Bio, Inc. stock logo
GRI
GRI Bio
+25.76%+50.00%+88.24%+44.00%-92.95%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
+0.88%-33.26%-42.05%-50.86%-91.36%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
+0.87%-5.33%-4.11%+3.61%-61.53%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00%-15.69%-10.00%+18.03%-78.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GRI Bio, Inc. stock logo
GRI
GRI Bio
2.00
Hold$32.001,011.11% Upside
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
2.40
Hold$9.005,132.56% Upside
Scienture Holdings, Inc. stock logo
SCNX
Scienture
2.00
Hold$1.50302.14% Upside
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GRI, ZIVO, MDCX, and SCNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/28/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy
7/17/2026
GRI Bio, Inc. stock logo
GRI
GRI Bio
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/8/2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/24/2026
Scienture Holdings, Inc. stock logo
SCNX
Scienture
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/A$4.70 per shareN/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/A($0.03) per shareN/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$821.32K18.65N/AN/A$1.56 per share0.24
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$15.85K957.35N/AN/A($0.81) per share-4.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$11.96M-$38.37N/AN/AN/AN/A-134.03%-106.83%11/13/2026 (Estimated)
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-$35.46M-$2.46N/AN/AN/AN/A-3,137.84%-263.24%11/13/2026 (Estimated)
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-$41.51M-$2.10N/AN/AN/AN/A-53.51%-42.47%11/12/2026 (Estimated)
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-$7.78M-$1.40N/AN/AN/AN/AN/A-2,240.92%N/A

Latest GRI, ZIVO, MDCX, and SCNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$1.19-$0.91+$0.28-$0.91N/AN/A
8/13/2026Q2 2026
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-$0.09-$0.07+$0.02-$0.07$1.96 million$0.34 million
8/12/2026Q2 2026
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
-$0.1275-$0.21-$0.0825-$0.21N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/AN/A
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/AN/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/A
10.30
10.30
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A
1.57
1.57
Scienture Holdings, Inc. stock logo
SCNX
Scienture
0.15
3.04
2.97
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/A
0.17
0.17

Institutional Ownership

CompanyInstitutional Ownership
GRI Bio, Inc. stock logo
GRI
GRI Bio
33.95%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
5.68%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
12.83%

Insider Ownership

CompanyInsider Ownership
GRI Bio, Inc. stock logo
GRI
GRI Bio
8.73%
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
8.10%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
21.39%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
48.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GRI Bio, Inc. stock logo
GRI
GRI Bio
12.19 million2.00 millionNot Optionable
Medicus Pharma Ltd stock logo
MDCX
Medicus Pharma
N/A63.18 million58.06 millionN/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
N/A41.06 million32.28 millionN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
104.22 million2.91 millionNot Optionable

Recent News About These Companies

Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 12, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260512411739/en/zivo-bioscience-inc.-announces-transition-to-otcid-marketplace/
Zivo Bioscience Inc. Wt
April 11, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/zivow
ZIVO Bioscience Provides Special Letter to Shareholders
March 27, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260327190358/en/ZIVO-Bioscience-Provides-Special-Letter-to-Shareholders/
Maxim Group Reaffirms Their Hold Rating on Zivo Bioscience (ZIVO)
December 15, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ZIVO/pressreleases/36474537/maxim-group-reaffirms-their-hold-rating-on-zivo-bioscience-zivo/
ZIVO Bioscience releases letter to shareholders
September 14, 2025  |  wattagnet.comW
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250910182550/en/zivo-bioscience-ceo-letter-to-shareholders-highlights-progress-with-human-nutrition-and-animal-therapeutic-businesses/
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry
June 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250620564330/en/zivo-bioscience-and-leading-global-animal-health-company-to-advance-zivo%e2%80%99s-immune-enhancing-compounds-in-poultry/
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 7, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/university-delaware-study-identifies-optimal-215400486.html
University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250506414477/en/university-of-delaware-study-identifies-optimal-formulation-of-zivo%e2%80%99s-active-ingredients-for-further-testing-to-mitigate-avian-influenza-in-poultry/
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 6, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250206639313/en/zivo-bioscience-plans-new-study-with-university-of-delaware-to-combat-avian-influenza-in-poultry/
Zivo Bioscience issues new shares, raises $1.5 million
January 28, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/zivo-bioscience-issues-new-shares-raises-1-5-million/ar-AA1xZjTM
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed
January 1, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tuesdays-insider-activity-top-buys-and-sells-in-us-stocks-revealed-93CH-3793355
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241220941955/en/ZIVO-Bioscience-Reports-Preliminary-Efficacy-of-its-Proprietary-Active-Ingredients-in-the-Battle-Against-Avian-Influenza/
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023
March 18, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/03/zivo-stock-earnings-zivo-bioscience-for-q4-of-2023/?utm_source=marketbeat&utm_medium=referral
Harmony Biosciences Holdings
March 4, 2024  |  forbes.comhttps://www.forbes.com/companies/harmony-biosciences-holdings/
Regencell Bioscience Holdings Ltd RGC
February 1, 2024  |  morningstar.comM
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/zivo-bioscience-announces-uplisting-otcqb-130000877.html?.tsrc=rss
Ideaya Biosciences
January 18, 2024  |  forbes.comhttps://www.forbes.com/companies/ideaya-biosciences/
Dare Bioscience Inc DARE
January 14, 2024  |  morningstar.comM
Zivo Bioscience Inc (ZIVO) USD0.001
November 11, 2023  |  hl.co.ukhttps://www.hl.co.uk/shares/shares-search-results/z/zivo-bioscience-inc-usd1.001/costs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
IonQ logo surrounded by quantum computing hardware, highlighting IONQ stock and quantum technology sector demand.
IonQ Sparks a Quantum Grid Revolution
By Jeffrey Neal Johnson | August 7, 2026
Metallic geometric logo mounted on a dark wall, with blurred server racks visible in the background.
Marvell Constructs an AI Moat With Alphabet Warrants
By Jeffrey Neal Johnson | August 21, 2026
Rendering of an electric vertical takeoff aircraft (eVTOL) on a rooftop landing pad above a city skyline.
Cleared for Takeoff: Archer Aviation Changes the Math on eVTOL
By Jeffrey Neal Johnson | August 13, 2026
Split image showing a highway with traffic, a water treatment facility with blue pipes, and a cellular tower amid city skylines.
3 Infrastructure Stocks Built Around the Backbone of the Economy
By Chris Markoch | August 18, 2026
Amazon logo displayed in front of a blue stock market price chart background.
Amazon Plugs $18B Into the Southern Power Grid
By Jeffrey Neal Johnson | August 19, 2026
GRI Bio stock logo

GRI Bio NASDAQ:GRI

$2.88 +0.59 (+25.76%)
As of 09/4/2026 04:00 PM Eastern

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Medicus Pharma stock logo

Medicus Pharma NASDAQ:MDCX

$0.17 +0.00 (+0.88%)
As of 09/4/2026 04:00 PM Eastern

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Scienture stock logo

Scienture NASDAQ:SCNX

$0.37 +0.00 (+0.87%)
As of 09/4/2026 04:00 PM Eastern

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVO

$3.60 0.00 (0.00%)
As of 09/4/2026

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas